| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $29.8M | -7.3% |
| SG&A Expense | $28.8M | +122.9% |
| Operating Income | -$58.6M | +56.6% |
| Pre-tax Income | -$49.8M | +29.1% |
| Income Tax | $1K | +100.6% |
| Net Income | -$49.8M | +60.1% |
| EPS (Basic) | -$2.34 | -6.8% |
| EPS (Diluted) | -$2.34 | -6.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.2M | -89.1% |
| Current Assets | $211.9M | +12.7% |
| Total Assets | $215.3M | +14.2% |
| Current Liabilities | $10.4M | +116.9% |
| Total Liabilities | $11.2M | +130.2% |
| Stockholders' Equity | $204.1M | +11.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$59.4M | +34.0% |
| Capital Expenditures | $468K | -95.7% |
| Investing Cash Flow | -$154.5M | -168.2% |
| Financing Cash Flow | $199.0M | — |
| Free Cash Flow | -$59.9M | +40.7% |